We found anti-GPIbα-mediated platelet effects were susceptible to therapeutic intervention in vivo, as the sialidase inhibitors, DANA and oseltamivir, were able to rescue anti-GPIbα-mediated thrombocytopenia in mice. This evidence concerns the gene GP1BA and Thrombocytopenia.